Navigation Links
bioMETRX, Inc. Initiates Integration of Personnel and Assets of Sequiam Corp.
Date:4/22/2008

Biometric Investors, LLC funds Company Initial $250,000 under March

agreement

JERICHO, N.Y., April 22 /PRNewswire-FirstCall/ -- bioMETRX Inc., (OTC Bulletin Board: BMRX), a leading developer and supplier of consumer-based finger-activated products, today announced that it has commenced the initial integration of the assets and former personnel of Sequiam Corporation (OTC Bulletin Board: SQUME) through a previously announced agreement with Biometric Investors, LLC.

"We were notified last week by Biometric Investors, LLC that it has secured an order from the bankruptcy court to take immediate possession of Sequiam's assets. We have implemented a plan to incorporate many former Sequiam employees into our core business, and to take immediate possession of the equipment, inventory and technology base. We expect a smooth transition of those assets into bioMETRX over the next few weeks", stated Mark Basile, Chief Executive Officer at bioMETRX, Inc.

In addition, Biometric Investors, LLC has funded $250,000 to bioMETRX as part of the asset acquisition and financing agreement between the companies. The total financing, once completed, will significantly increase the Company's ability to expand its proprietary smartTOUCH(TM) and smartFIT technology across many vertical markets and continue to establish itself as the most dominant global leader in the development of low cost, low power OEM biometric integration products.

As the global leader in consumer biometric product engineering, development and sales, bioMETRX's technology has proven to be the most dependable and robust consumer biometric platform available today. It's smartTOUCH product line is just starting to make its way into the marketplace, having shipped over 18,000 units of its garage door opener to Home Depot last quarter. The smartTOUCH line is now being expanded to door locks, cabinet locks, mailboxes and luggage. The company's new smartFIT te
'/>"/>

SOURCE bioMETRX Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Lorus initiates development program exploring novel route of administration for LOR-2040
2. SemBioSys initiates toxicology study for safflower-produced insulin
3. Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data
4. Aegera initiates Phase 1 clinical trial of AEG33773 - A small molecule in development for diabetic neuropathic pain
5. TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia
6. NicOx Initiates Two Large ABPM Studies for Naproxcinod in Hypertensive Patients with Osteoarthritis
7. Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
8. Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
9. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
10. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
11. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Sigma-Aldrich Corporatio...Q OMX conference on Tuesday, December 1st at 1:45 ...es may listen via live audio broadcast over the In...a a ldrich.com/ . Users can click the "Webcast...Aldrich: Sigma-Aldrich is a leading Life Science...
(Date:11/24/2009)... Nov. 24 NeurogesX, Inc....used on developing and commercializing novel pain ... DiTonno, President and Chief Executive Officer, i...ffray Health Care Conference, to be held December ..., New York. ,, Mr. DiTonno and Stephen Ghiglie...
(Date:11/24/2009)... endpoint has been met for patients with advanced-...QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEte..."Company"), a global biopharmaceutical company foc...unced positive efficacy data from a Phase 2 study ...S-108 (formerly AN-152), in patients with advanced...
(Date:11/24/2009)..., Nov. 24 Genomic Health... Scott, Genomic Health,s Executive Chairman, will ...re Conference in New York City on Tuesday, Decembe...ive and subsequently archived webcast of the prese...enomic Health,s website at http://investor.genomi...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...s Technologies, Inc. (CTi), a professional consult... Science Applications International Corporation (N...th the National Institute of Allergy and Infectiou...ealth (NIH). The contract to SAIC is for $19 mill...will provide regulatory affairs, technical and adm...
...based company has,successfully grown the first Low...gnificantly lower levels of harmful radioactive ca...hildren nourished with safer, low radiocarbon,Life...r genetic damage events,over their lifetime. By re...efects may also be reduced. Since genetic damage m...
...otech, Inc.,(Nasdaq: OSTE ), a leader in the eme...healing, announced today that its Board of Directo... which up to $5.0 million of,Osteotech,s common st...cuted,from time to time at current market prices t...ctions in such amounts as management deems appropr...
Other Biology Technology:Cascades Technologies, Inc. and SAIC Team on $19 Million Contract with National Institutes of Health 2World's First Low Radiocarbon Food May Reduce Risks of Cancer and Birth Defects, and Possibly Even Slow the Aging Process 2Osteotech Announces Stock Repurchase Program 2
(Date:11/26/2009)...09) Whitehead researchers have developed a new ty...pecific genes and proteins used by pathogens, acco...an cell cultures genes are present in two copies: ...her. Gene inactivation by mutation is therefore in...e second copy usually remains active and takes ove...
(Date:11/25/2009)...easy lives. In addition to mammalian immune system... called bacteriophages, viruses that kill half the...teria and another class of microorganisms called a...uch as deep-sea volcanic vents) manage just fine, ...fense system that helps protect them from many vir...
(Date:11/25/2009)...nt professors recently received funding from the N...rch beneficial to understanding the environment. T...ackwood, assistant professor in the Department of ... two separate research projects. , His first pro...ties and Functions from the Leaf to the Landscape,...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Kent State University professors focus research on the environment with grants totaling $890,000 2Paper Highlights Antimicrobial Effectiveness of Medical Grade Honey in Topical Wound Care 52801 1Paper Highlights Antimicrobial Effectiveness of Medical Grade Honey in Topical Wound Care 52801 2Radiation Plus Chemo a Good Option in Lung Cancer 52797 1Radiation Plus Chemo a Good Option in Lung Cancer 52797 2Genetic testing may be valuable in treating colorectal cancer 52793 1Genetic testing may be valuable in treating colorectal cancer 52793 2
...WASHINGTONThe science and technology policymaking ...at the next president can better address key issue..., to national security, and the ability of the Uni...lly. The report,s primary recommendations are that...nally respected leader to be Assistant for Science...
...Washington, DC, June 13, 2008 Mary Tyler Moore, t...tional chairman, and her husband, S. Robert Levine...Clinical Research Award" to a team of Florida scie...gton, DC. , The recipients of this year,s prestig...he JDRF Gene Therapy Center for Diabetes and Diabe...
... This release is available in German . , Beca...ndling it, tetrachloromethane (carbon tetrachlorid... countries. However, the processes used in the pro... chloroform (trichloromethane, CHCl3), also produc... rid of this unwanted substance? A team headed by ...
Other Biology News:White House science office needs upgrade 2White House science office needs upgrade 3Florida researchers receive JDRF 'Excellence in Clinical Research Award' 2Fair trade 2
Rabbit Anti-Human Q86TS7 Polyclonal Antibody, Unconjugated from Atlas Antibodies
...ontains 4 deuterium atoms at the 9, 10, 12, and 13...standard for the quantification of 9(S)-HODE by GC...y the lipoxygenation of linoleic acid in both plan...rotic plaques, as an esterified component of membr...
12(S)-HETE-d8, Deuterium Conjugated/Tagged from Cayman Chemical
Silencer Pre-designed siRNA, HPLC purified, annealed from Ambion
Biology Products: